12:00 AM
 | 
Dec 17, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

CureVac preclinical data

In mice infected with influenza A, RNActive vaccines were immunogenic and provided full protection against infection with H1N1 and H5N1...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >